Literature DB >> 25374376

Antigenotoxic capacity of beta-caryophyllene in mouse, and evaluation of its antioxidant and GST induction activities.

Isela Alvarez-González1, Eduardo Madrigal-Bujaidar, Seydi Castro-García.   

Abstract

The present report was designed to determine the antigenotoxic capacity of beta-caryophyllene (BC) on the damage induced by benzo(a)pyrene (BaP) in mouse. We found no genotoxic potential of BC, and a significant inhibitory effect on the number of sister-chromatid exchanges (SCE) and chromosomal aberrations induced by BaP. The three tested doses of the agent (20, 200, and 2,000 mg/kg) produced a dose-dependent decrease of the two evaluated cytogenetic parameters. In comparison with the effect induced by BaP, the best inhibitory effect (about 80%) was obtained with the high tested dose of BC considering the two evaluated parameters. Other aim of the study was to explore whether in this effect participated the BC antioxidant capacity and/or its effect as inducer of GST activity. We found a dose-dependent decrease induced by BC in regard to both the oxidation of lipids and proteins produced by BaP.In the case of GST, when BC was administered alone we found a mean increase of 64% of the enzyme activity, respect to the control level, and when BC was administered in mice treated with BaP the increase obtained with the high dose of BC reached 27%. Therefore, our data established no in vivo genotoxicity by BC, and a significant antigenotoxic potential of the compound, which may be related with its capacity to block the molecular oxidation and to stimulate the GST activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25374376     DOI: 10.2131/jts.39.849

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  7 in total

1.  β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway.

Authors:  Qian Zhang; Ruidi An; Xiaocui Tian; Mei Yang; Minghang Li; Jie Lou; Lu Xu; Zhi Dong
Journal:  Neurochem Res       Date:  2017-02-24       Impact factor: 3.996

2.  β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; M Emdadul Haque
Journal:  Mol Cell Biochem       Date:  2016-06-17       Impact factor: 3.396

3.  β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.

Authors:  Niraj Kumar Jha; Charu Sharma; Hebaallah Mamdouh Hashiesh; Seenipandi Arunachalam; Mf Nagoor Meeran; Hayate Javed; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

4.  Engineering Escherichia coli for the production of terpene mixture enriched in caryophyllene and caryophyllene alcohol as potential aviation fuel compounds.

Authors:  Weihua Wu; Fang Liu; Ryan W Davis
Journal:  Metab Eng Commun       Date:  2018-01-05

5.  Hypocholesterolemic effect of β-caryophyllene in rats fed cholesterol and fat enriched diet.

Authors:  Amani A Harb; Yasser K Bustanji; Shtaywy S Abdalla
Journal:  J Clin Biochem Nutr       Date:  2018-02-07       Impact factor: 3.114

Review 6.  Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation.

Authors:  Rosaria Scandiffio; Federica Geddo; Erika Cottone; Giulia Querio; Susanna Antoniotti; Maria Pia Gallo; Massimo E Maffei; Patrizia Bovolin
Journal:  Nutrients       Date:  2020-10-26       Impact factor: 5.717

Review 7.  Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.

Authors:  Hebaallah Mamdouh Hashiesh; Mohamed F Nagoor Meeran; Charu Sharma; Bassem Sadek; Juma Al Kaabi; Shreesh K Ojha
Journal:  Nutrients       Date:  2020-09-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.